youtube_live
Q2 2027 earnings • in 4 days
See detailschevron_right
GLAXO:NSE
GlaxoSmithKline Pharmaceuticals Ltd
2 508,70 ₹
arrow_downward
-0,25%(-6,40) 1D
30 հոկ, 15:30:02 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAXO...
Open
2 527,60 ₹
High
2 528,90 ₹
Low
2 479,30 ₹
Mkt. cap
424,99 մլրդ
Avg. vol.
64,38 հզր
Volume
56,35 հզր
Dividend
2,27%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,79
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
Open
2 527,60 ₹
High
2 528,90 ₹
Low
2 479,30 ₹
Mkt. cap
424,99 մլրդ
Avg. vol.
64,38 հզր
Volume
56,35 հզր
Dividend
2,27%
Quarterly dividend
14,25 ₹
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
39,79
52-wk high
3 120,70 ₹
52-wk low
2 088,10 ₹
EPS
63,05 ₹
Shares outstanding
169,41 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Nasdaq
·
21 րոպե առաջ
Chartstopper: October 30, 2026
Daily Kos
·
44 րոպե առաջ
There goes the Nasdaq
Investing.com
·
12 րոպե առաջ
Okta jumps after-hours following tapped inclusion in the S&P 500
WSJ
·
10 րոպե առաջ
Opinion | An AI Halloween Market Scare
Profile
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia
About GlaxoSmithKline Pharmaceuticals Ltd